A new artificial intelligence (AI)–based tool shows promise for improving surveillance in patients treated with endoscopic eradication therapies for Barrett’s esophagus (BE)-related dysplasia and early esophageal adenocarcinoma. BE is the only known condition that precedes esophageal adenocarcinoma – an aggressive cancer with high mortality rates.
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
On November 15, 2023, CBSA held its 20th Annual Awards Celebration presented by AGC Biologics. This annual celebration highlights the spirit and drive of Colorado’s vibrant life sciences ecosystem, bringing together hundreds of leaders and […]
There are a dizzying number of tips, hacks and recommendations on how to stay healthy, from dietary supplements to what color of clothes promotes optimal wellness. Some of these tips are helpful and based on good evidence, while others are not. […]
When Joel Friedlander, DO, MA-bioethics, travels to Vienna this month, he will check another box on a journey that’s been a series of peaks, and a few valleys, on the way to a breakthrough medical […]
Copyright © 2026 Biotech Networks
